Health Information
It may be due to the reduction of hepatocytes in cirrhosis patient, which promotes the secretion of HGF and then activates c-Met to increase hepatocytes proliferation
Real-World Effectiveness Across Drug Comparisons In expanded routine-care populations, semaglutide reduced the 1-year risk of myocardial infarction or stroke to 1.5% compared with 1.7% with sitagliptin (HR, 0.82
A two-year clinical trial looked at a different GLP-1 drug
Contact your GP for routine assessment if: Urinary frequency significantly disrupts daily activities or sleep You notice persistent changes in urine colour, smell, or appearance Urinary symptoms persist beyond the initial adjustment period (typically 48 weeks) You have concerns about medication side effects or diabetes control Your healthcare provider can perform appropriate investigations, including urinalysis, renal function tests, and HbA1c measurement, to determine the underlying cause of urinary changes and adjust your treatment plan accordingly
10.2337/dc10-2415 130 ZhengH.CaiL.RinamanL
